The Role of Platelet Function Testing in Improving Clinical Outcomes

The following Expert Roundtable Discussion was held on November 1, 2017. The discussion focused primarily on: (1) Factors that contribute toward inadequate antiplatelet drug responsiveness; (2) personalizing antiplatelet therapy to improve clinical outcomes; (3) the limitations of platelet function testing; (4) what is the optimal timing for platelet function testing: at the time of ACS or post-treatment; (5) the role of ROTEM and TEG in addressing clot integrity and platelet function; and (6) the current role for platelet function testing in evaluating patients and outcomes. [Published online ahead of print May 14, 2018.] (Med Roundtable Cardiovasc Ed. 2018 May 14.)